---
title: "CHINA REFORM HEALTH released its performance for the first half of the year, with a net loss attributable to the parent company of 99.0907 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254773847.md"
description: "According to the Zhitong Finance APP, CHINA REFORM HEALTH released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 95.5301 million yuan, a year-on-year decrease of 30.47%. The net loss attributable to shareholders of the listed company was 99.0907 million yuan, and the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 98.8113 million yuan, with a basic loss per share of 0.1012 yuan"
datetime: "2025-08-27T09:36:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254773847.md)
  - [en](https://longbridge.com/en/news/254773847.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254773847.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/254773847.md) | [繁體中文](https://longbridge.com/zh-HK/news/254773847.md)


# CHINA REFORM HEALTH released its performance for the first half of the year, with a net loss attributable to the parent company of 99.0907 million yuan

According to the Zhitong Finance APP, CHINA REFORM HEALTH (000503.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 95.5301 million yuan, a year-on-year decrease of 30.47%. The net loss attributable to shareholders of the listed company was 99.0907 million yuan, and the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 98.8113 million yuan, with a basic loss per share of 0.1012 yuan

### Related Stocks

- [CHINA REFORM HEALTH (000503.CN)](https://longbridge.com/en/quote/000503.CN.md)

## Related News & Research

- [Clinton says Trump told him of 'some great times' with Jeffrey Epstein](https://longbridge.com/en/news/277533388.md)
- [08:03 ETDecentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health](https://longbridge.com/en/news/277468910.md)
- [03:14 ETGuide Redefines Thermal Excellence at IWA OutdoorClassics 2026](https://longbridge.com/en/news/277344346.md)
- [Vedanta says declared preferred bidder for Karnapodikonda bauxite block in Odisha](https://longbridge.com/en/news/277450980.md)
- [06:30 ETECR 2026: Esaote Group presenta avances en ultrasonido, resonancia magnética e imagen empresarial](https://longbridge.com/en/news/277454917.md)